Clinical trial
Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT00216749 is registered in ClinicalTrials.gov with Korea Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS
- Lead sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- October 31, 2007
- Enrollment
- 650 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.